10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,877 | -26.1% | 1,694 | 0.0% | 0.01% | -14.3% |
| Q2 2023 | $94,592 | +0.1% | 1,694 | 0.0% | 0.01% | -6.7% |
| Q1 2023 | $94,508 | +69.7% | 1,694 | +10.9% | 0.02% | +66.7% |
| Q4 2022 | $55,680 | -99.9% | 1,528 | +12.4% | 0.01% | +28.6% |
| Q3 2022 | $38,732,000 | -8.5% | 1,360 | +45.5% | 0.01% | 0.0% |
| Q2 2022 | $42,308,000 | -15.7% | 935 | +41.7% | 0.01% | -12.5% |
| Q1 2022 | $50,206,000 | -48.9% | 660 | 0.0% | 0.01% | -46.7% |
| Q4 2021 | $98,313,000 | +2.3% | 660 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $96,082,000 | -25.7% | 660 | 0.0% | 0.02% | -31.8% |
| Q2 2021 | $129,241,000 | +8.2% | 660 | 0.0% | 0.02% | -4.3% |
| Q1 2021 | $119,460,000 | +27.8% | 660 | 0.0% | 0.02% | +15.0% |
| Q4 2020 | $93,456,000 | – | 660 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |